Abstract
AbstractUnderstanding the development of humoral immune responses of children and adolescents to SARS-CoV-2 is essential for designing effective public health measures. Here we examine the changes of humoral immune response in school-aged children and adolescents during the COVID-19 pandemic (June 2020 to July 2022), with a specific interest in the Omicron variant (beginning of 2022). In our study “Ciao Corona”, we assess in each of the five testing rounds between 1874 and 2500 children and adolescents from 55 schools in the canton of Zurich with a particular focus on a longitudinal cohort (n=751). By July 2022, 96.9% (95% credible interval 95.3–98.1%) of children and adolescents have SARS-CoV-2 anti-spike IgG (S-IgG) antibodies. Those with hybrid immunity or vaccination have higher S-IgG titres and stronger neutralising responses against Wildtype, Delta and Omicron BA.1 variants compared to those infected but unvaccinated. S-IgG persist over 18 months in 93% of children and adolescents. During the study period one adolescent was hospitalised for less than 24 hours possibly related to an acute SARS-CoV-2 infection. These findings show that the Omicron wave and the rollout of vaccines boosted S-IgG titres and neutralising capacity. Trial registration number: NCT04448717. https://clinicaltrials.gov/ct2/show/NCT04448717.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference83 articles.
1. Szépfalusi, Z. et al. Lessons from low seroprevalence of SARS‐CoV‐2 antibodies in schoolchildren: a cross‐sectional study. Pediatr. Allergy Immunol. 32, 762–770 (2021).
2. Oeser, C. et al. Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination. J. Infect. 84, 418–467 (2022).
3. Ladhani, S. N. et al. SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study. Lancet Child Adolesc. Health 5, 417–427 (2021).
4. Ott, R. et al. SARS-CoV-2 seroprevalence in preschool and school-age children —population screening findings from January 2020 to June 2022. Dtsch. Arztebl. Int. 119, 765–770 (2022).
5. Sorg, A.-L. et al. Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021. Nat. Commun. 13, 3128 (2022).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献